Do analysts prefer LXFR or AMTX?

Aemetis has a consensus target price of $11.88, suggesting a potential upside of 615.36%. Given Aemetis' higher probable upside, analysts clearly believe Aemetis is more favorable than Luxfer. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Luxfer 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.67 Aemetis 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has stronger valuation & earnings, LXFR or AMTX?

Luxfer has higher revenue and earnings than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than Luxfer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Luxfer $384.60M 1.20 $7.70M $0.22 77.75 Aemetis $197.63M 0.59 -$77M -$1.19 N/A

Is LXFR or AMTX more profitable?

Luxfer has a net margin of 1.56% compared to Aemetis' net margin of -35.43%. Luxfer's return on equity of 12.14% beat Aemetis' return on equity. Company Net Margins Return on Equity Return on Assets Luxfer 1.56% 12.14% 7.25% Aemetis -35.43% N/A -33.44%

Which has stronger valuation and earnings, ALTO or AMTX?

Alto Ingredients has higher revenue and earnings than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than Alto Ingredients, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alto Ingredients $917.93M 0.47 $13.34M $0.37 15.19 Aemetis $197.63M 0.59 -$77M -$1.19 N/A

Is ALTO or AMTX more profitable?

Alto Ingredients has a net margin of 3.20% compared to Aemetis' net margin of -35.43%. Alto Ingredients' return on equity of 9.77% beat Aemetis' return on equity. Company Net Margins Return on Equity Return on Assets Alto Ingredients 3.20% 9.77% 5.81% Aemetis -35.43% N/A -33.44%

Does the media prefer ALTO or AMTX?

In the previous week, Alto Ingredients and Alto Ingredients both had 5 articles in the media. Aemetis' average media sentiment score of 0.54 beat Alto Ingredients' score of 0.10 indicating that Aemetis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alto Ingredients 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Aemetis 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer AMTX or VHI?

Aemetis currently has a consensus target price of $11.88, suggesting a potential upside of 615.36%. Given Aemetis' stronger consensus rating and higher possible upside, equities research analysts clearly believe Aemetis is more favorable than Valhi. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aemetis 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Valhi 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation & earnings, AMTX or VHI?

Valhi has higher revenue and earnings than Aemetis. Valhi is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aemetis $197.63M 0.59 -$77M -$1.19 N/A Valhi $2.08B 0.19 -$57.60M -$2.54 N/A

Is AMTX or VHI more profitable?

Valhi has a net margin of -3.45% compared to Aemetis' net margin of -35.43%. Aemetis' return on equity of 0.00% beat Valhi's return on equity. Company Net Margins Return on Equity Return on Assets Aemetis -35.43% N/A -33.44% Valhi -3.45% -4.29% -2.23%

Does the media favor AMTX or VHI?

In the previous week, Aemetis had 3 more articles in the media than Valhi. MarketBeat recorded 5 mentions for Aemetis and 2 mentions for Valhi. Valhi's average media sentiment score of 0.59 beat Aemetis' score of 0.54 indicating that Valhi is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aemetis 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Valhi 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, AMTX or OEC?

Orion has higher revenue and earnings than Aemetis. Orion is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aemetis $197.63M 0.59 -$77M -$1.19 N/A Orion $1.81B 0.19 -$70.10M -$1.60 N/A

Is AMTX or OEC more profitable?

Orion has a net margin of -4.98% compared to Aemetis' net margin of -35.43%. Orion's return on equity of 2.23% beat Aemetis' return on equity. Company Net Margins Return on Equity Return on Assets Aemetis -35.43% N/A -33.44% Orion -4.98% 2.23% 0.47%

Does the media favor AMTX or OEC?

In the previous week, Aemetis had 3 more articles in the media than Orion. MarketBeat recorded 5 mentions for Aemetis and 2 mentions for Orion. Aemetis' average media sentiment score of 0.54 beat Orion's score of -1.23 indicating that Aemetis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aemetis 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Orion 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative

Is SAFX or AMTX more profitable?

XCF Global Capital has a net margin of 300.85% compared to Aemetis' net margin of -35.43%. Aemetis' return on equity of 0.00% beat XCF Global Capital's return on equity. Company Net Margins Return on Equity Return on Assets XCF Global Capital 300.85% -588.22% -29.08% Aemetis -35.43% N/A -33.44%

Does the media refer more to SAFX or AMTX?

In the previous week, Aemetis had 1 more articles in the media than XCF Global Capital. MarketBeat recorded 5 mentions for Aemetis and 4 mentions for XCF Global Capital. Aemetis' average media sentiment score of 0.54 beat XCF Global Capital's score of 0.40 indicating that Aemetis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment XCF Global Capital 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Aemetis 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Aemetis (AMTX) Competitors

$1.66 +0.07 (+4.40%)

Closing price 04:00 PM Eastern

Extended Trading

$1.68 +0.02 (+1.45%)

As of 06:03 PM Eastern

Compare

AMTX vs. LXFR, ALTO, VHI, OEC, and SAFX

Should you buy Aemetis stock or one of its competitors? MarketBeat compares Aemetis with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aemetis include Luxfer (LXFR), Alto Ingredients (ALTO), Valhi (VHI), Orion (OEC), and XCF Global Capital (SAFX). These companies are all part of the "chemicals" industry.

How does Aemetis compare to Luxfer?

Luxfer (NYSE:LXFR) and Aemetis (NASDAQ:AMTX) are both small-cap chemicals companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership, analyst recommendations and media sentiment.

Luxfer has higher revenue and earnings than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than Luxfer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Luxfer	$384.60M	1.20	$7.70M	$0.22	77.75
Aemetis	$197.63M	0.59	-$77M	-$1.19	N/A

Luxfer has a net margin of 1.56% compared to Aemetis' net margin of -35.43%. Luxfer's return on equity of 12.14% beat Aemetis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Luxfer	1.56%	12.14%	7.25%
Aemetis	-35.43%	N/A	-33.44%

90.8% of Luxfer shares are owned by institutional investors. Comparatively, 27.0% of Aemetis shares are owned by institutional investors. 2.0% of Luxfer shares are owned by insiders. Comparatively, 13.0% of Aemetis shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Luxfer has a beta of 1.12, suggesting that its stock price is 12% more volatile than the broader market. Comparatively, Aemetis has a beta of 1.44, suggesting that its stock price is 44% more volatile than the broader market.

In the previous week, Aemetis had 5 more articles in the media than Luxfer. MarketBeat recorded 5 mentions for Aemetis and 0 mentions for Luxfer. Luxfer's average media sentiment score of 1.00 beat Aemetis' score of 0.54 indicating that Luxfer is being referred to more favorably in the media.

Company	Overall Sentiment
Luxfer	Positive
Aemetis	Positive

Aemetis has a consensus target price of $11.88, suggesting a potential upside of 615.36%. Given Aemetis' higher probable upside, analysts clearly believe Aemetis is more favorable than Luxfer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Luxfer	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.67
Aemetis	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Luxfer beats Aemetis on 12 of the 17 factors compared between the two stocks.

How does Aemetis compare to Alto Ingredients?

Alto Ingredients (NASDAQ:ALTO) and Aemetis (NASDAQ:AMTX) are both small-cap chemicals companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

Alto Ingredients has higher revenue and earnings than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than Alto Ingredients, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alto Ingredients	$917.93M	0.47	$13.34M	$0.37	15.19
Aemetis	$197.63M	0.59	-$77M	-$1.19	N/A

Alto Ingredients currently has a consensus target price of $10.00, suggesting a potential upside of 77.94%. Aemetis has a consensus target price of $11.88, suggesting a potential upside of 615.36%. Given Aemetis' higher probable upside, analysts clearly believe Aemetis is more favorable than Alto Ingredients.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alto Ingredients	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Aemetis	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Alto Ingredients has a net margin of 3.20% compared to Aemetis' net margin of -35.43%. Alto Ingredients' return on equity of 9.77% beat Aemetis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alto Ingredients	3.20%	9.77%	5.81%
Aemetis	-35.43%	N/A	-33.44%

In the previous week, Alto Ingredients and Alto Ingredients both had 5 articles in the media. Aemetis' average media sentiment score of 0.54 beat Alto Ingredients' score of 0.10 indicating that Aemetis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alto Ingredients	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aemetis	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

42.4% of Alto Ingredients shares are owned by institutional investors. Comparatively, 27.0% of Aemetis shares are owned by institutional investors. 4.3% of Alto Ingredients shares are owned by company insiders. Comparatively, 13.0% of Aemetis shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Alto Ingredients has a beta of 0.13, meaning that its stock price is 87% less volatile than the broader market. Comparatively, Aemetis has a beta of 1.44, meaning that its stock price is 44% more volatile than the broader market.

Summary

Alto Ingredients beats Aemetis on 9 of the 14 factors compared between the two stocks.

How does Aemetis compare to Valhi?

Aemetis (NASDAQ:AMTX) and Valhi (NYSE:VHI) are both small-cap chemicals companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, valuation, profitability, media sentiment, analyst recommendations, earnings, institutional ownership and dividends.

Aemetis has a beta of 1.44, meaning that its stock price is 44% more volatile than the broader market. Comparatively, Valhi has a beta of 0.96, meaning that its stock price is 4% less volatile than the broader market.

Aemetis currently has a consensus target price of $11.88, suggesting a potential upside of 615.36%. Given Aemetis' stronger consensus rating and higher possible upside, equities research analysts clearly believe Aemetis is more favorable than Valhi.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aemetis	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Valhi	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Valhi has a net margin of -3.45% compared to Aemetis' net margin of -35.43%. Aemetis' return on equity of 0.00% beat Valhi's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aemetis	-35.43%	N/A	-33.44%
Valhi	-3.45%	-4.29%	-2.23%

27.0% of Aemetis shares are owned by institutional investors. Comparatively, 3.8% of Valhi shares are owned by institutional investors. 13.0% of Aemetis shares are owned by company insiders. Comparatively, 0.2% of Valhi shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Aemetis had 3 more articles in the media than Valhi. MarketBeat recorded 5 mentions for Aemetis and 2 mentions for Valhi. Valhi's average media sentiment score of 0.59 beat Aemetis' score of 0.54 indicating that Valhi is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aemetis	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Valhi	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Valhi has higher revenue and earnings than Aemetis. Valhi is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aemetis	$197.63M	0.59	-$77M	-$1.19	N/A
Valhi	$2.08B	0.19	-$57.60M	-$2.54	N/A

Summary

Aemetis beats Valhi on 11 of the 16 factors compared between the two stocks.

How does Aemetis compare to Orion?

Aemetis (NASDAQ:AMTX) and Orion (NYSE:OEC) are both small-cap chemicals companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, media sentiment, risk, valuation, earnings and dividends.

Aemetis currently has a consensus price target of $11.88, indicating a potential upside of 615.36%. Orion has a consensus price target of $5.92, indicating a potential downside of 3.08%. Given Aemetis' stronger consensus rating and higher possible upside, research analysts plainly believe Aemetis is more favorable than Orion.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aemetis	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Orion	4 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.20

27.0% of Aemetis shares are held by institutional investors. Comparatively, 94.3% of Orion shares are held by institutional investors. 13.0% of Aemetis shares are held by insiders. Comparatively, 3.1% of Orion shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Aemetis has a beta of 1.44, meaning that its stock price is 44% more volatile than the broader market. Comparatively, Orion has a beta of 1, meaning that its stock price has a similar volatility profile to the broader market.

Orion has higher revenue and earnings than Aemetis. Orion is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aemetis	$197.63M	0.59	-$77M	-$1.19	N/A
Orion	$1.81B	0.19	-$70.10M	-$1.60	N/A

Orion has a net margin of -4.98% compared to Aemetis' net margin of -35.43%. Orion's return on equity of 2.23% beat Aemetis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aemetis	-35.43%	N/A	-33.44%
Orion	-4.98%	2.23%	0.47%

In the previous week, Aemetis had 3 more articles in the media than Orion. MarketBeat recorded 5 mentions for Aemetis and 2 mentions for Orion. Aemetis' average media sentiment score of 0.54 beat Orion's score of -1.23 indicating that Aemetis is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aemetis	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Orion	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative

Summary

Aemetis beats Orion on 10 of the 16 factors compared between the two stocks.

How does Aemetis compare to XCF Global Capital?

XCF Global Capital (NASDAQ:SAFX) and Aemetis (NASDAQ:AMTX) are both small-cap chemicals companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations.

XCF Global Capital currently has a consensus target price of $0.70, indicating a potential upside of 52.91%. Aemetis has a consensus target price of $11.88, indicating a potential upside of 615.36%. Given Aemetis' higher possible upside, analysts plainly believe Aemetis is more favorable than XCF Global Capital.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
XCF Global Capital	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Aemetis	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

XCF Global Capital has a beta of -0.32, suggesting that its share price is 132% less volatile than the broader market. Comparatively, Aemetis has a beta of 1.44, suggesting that its share price is 44% more volatile than the broader market.

XCF Global Capital has higher earnings, but lower revenue than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than XCF Global Capital, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
XCF Global Capital	$20.82M	7.31	$74.02M	-$0.68	N/A
Aemetis	$197.63M	0.59	-$77M	-$1.19	N/A

XCF Global Capital has a net margin of 300.85% compared to Aemetis' net margin of -35.43%. Aemetis' return on equity of 0.00% beat XCF Global Capital's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
XCF Global Capital	300.85%	-588.22%	-29.08%
Aemetis	-35.43%	N/A	-33.44%

In the previous week, Aemetis had 1 more articles in the media than XCF Global Capital. MarketBeat recorded 5 mentions for Aemetis and 4 mentions for XCF Global Capital. Aemetis' average media sentiment score of 0.54 beat XCF Global Capital's score of 0.40 indicating that Aemetis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
XCF Global Capital	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aemetis	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

52.3% of XCF Global Capital shares are held by institutional investors. Comparatively, 27.0% of Aemetis shares are held by institutional investors. 0.1% of XCF Global Capital shares are held by insiders. Comparatively, 13.0% of Aemetis shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

XCF Global Capital and Aemetis tied by winning 7 of the 14 factors compared between the two stocks.

Get Aemetis News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AMTX vs. The Competition

Export

Metric	Aemetis	Biofuels Industry	Energy Sector	NASDAQ Exchange
Market Cap	$116.81M	$317.80M	$9.98B	$12.53B
Dividend Yield	N/A	0.87%	10.72%	8.00%
P/E Ratio	-1.39	3.36	19.28	24.37
Price / Sales	0.59	1.31	469.13	116.84
Price / Cash	N/A	14.62	36.83	49.36
Price / Book	-0.36	1.20	4.15	6.34
Net Income	-$77M	-$58.67M	$4.24B	$330.89M
7 Day Performance	-6.21%	-0.11%	1.94%	-1.08%
1 Month Performance	-15.31%	-3.90%	-4.25%	-0.48%
1 Year Performance	-44.30%	-12.99%	28.87%	19.89%

Aemetis Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AMTX Aemetis	2.342 of 5 stars	$1.66 +4.4%	$11.88 +615.4%	-45.9%	$116.81M	$197.63M	N/A	160
LXFR Luxfer	2.8342 of 5 stars	$17.36 +1.3%	N/A	+38.9%	$462.89M	$384.60M	78.91	1,350	Positive News
ALTO Alto Ingredients	4.6601 of 5 stars	$5.72 +2.9%	$10.00 +74.8%	+373.4%	$430.82M	$917.93M	15.46	420	Short Interest Increase Gap Up
VHI Valhi	0.485 of 5 stars	$14.31 -0.6%	N/A	-22.6%	$407.55M	$2.08B	N/A	2,263	News Coverage
OEC Orion	1.8095 of 5 stars	$5.51 -4.0%	$5.92 +7.4%	-46.4%	$323.67M	$1.81B	N/A	1,639	Negative News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AMTX) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aemetis (AMTX) Competitors